The primary mechanism involves interaction with Aly/REF export factor (ALYREF), thereby upregulating the stability of YAP1 mRNA in an m5C-dependent manner, activating the Hippo and β-catenin signaling pathways, and promoting NSCLC progression (37). The gene discussed is ALYREF; the disease is non-small cell lung carcinoma.